Safety and Efficacy of Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia

被引：0

作者：

Nicholls, Stephen ^{[1
]}

Nelson, Adam ^{[1
]}

Ditmarsch, Marc ^{[2
]}

Kastelein, John ^{[2
]}

Ballantyne, Christie ^{[3
]}

Ray, Kausik ^{[4
]}

Navar, Ann Marie ^{[5
]}

Nissen, Steven ^{[6
]}

Goldberg, Anne ^{[7
]}

Brunham, Liam ^{[8
]}

Wuerdeman, Erin ^{[9
]}

Neild, Annie ^{[10
]}

Kling, Douglas ^{[11
]}

Hsieh, Andrew ^{[12
]}

Ference, Brian ^{[13
]}

Laufs, Ulrich ^{[14
]}

Banach, Maciej ^{[15
]}

Mehran, Roxana ^{[16
]}

Catapano, Alberico ^{[17
]}

Davidson, Michael ^{[2
]}

机构：

[1] Victorian Heart Hosp, Clayton, Vic, Australia

[2] New Amsterdam Pharma, Amsterdam, Netherlands

[3] Baylor Coll Med, Houston, TX 77030 USA

[4] Imperial Coll London, London, England

[5] UT Southwestern Med Ctr, Dallas, TX USA

[6] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA

[7] Washington Univ, Sch Med, St Louis, MO USA

[8] Univ British C0lumbia, Vancouver, BC, Canada

[9] NewAmsterdam Pharma, Cincinnati, OH USA

[10] NewAmsterdam Pharma, Aventura, FL USA

[11] NewAmsterdam Pharma, Lebanon, NJ USA

[12] Univ Illinois, Long Grove, IL USA

[13] Deep Causal AI, Cambridge, England

[14] Univ Clin Leipzig, Leipzig, Germany

[15] Med Univ Lodz, Lodz, Poland

[16] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[17] Univ Milan, Milan, Italy

来源：

CIRCULATION | 2024年 / 150卷 / 25期

关键词：

CETP inhibitors; Lipids; Clinical trials; Dyslipidemia; Prevention;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4171281

引用

页码：E729 / E730

页数：2

共 50 条

[21] Early coronary calcifications are related to cholesterol burden in heterozygous familial hypercholesterolemia
Gallo, Antonio
Giral, Philippe
Carrie, Alain
Carreau, Valerie
Beliard, Sophie
Bittar, Randa
Maranghi, Marianna
Arca, Marcell
Cluzel, Philippe
Redheuil, Alban
Bruckert, Eric
Rosenbaum, David
JOURNAL OF CLINICAL LIPIDOLOGY, 2017, 11 (03) : 704 - 711
[22] Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance
Laufs, Ulrich
Banach, Maciej
Mancini, G. B. John
Gaudet, Daniel
Bloedon, LeAnne T.
Sterling, Lulu Ren
Kelly, Stephanie
Stroes, Erik S. G.
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (07):
[23] Berberine as a Supplement to Guideline- Based Lipid Management of a Patient With Heterozygous Familial Hypercholesterolemia: A Case Presentation
Epstein, Elizabeth S.
Goel, Kunal
Triffon, Douglas W.
CIRCULATION, 2023, 148
[24] Diagnosis and Management of Individuals With Heterozygous Familial Hypercholesterolemia: Too Late and Too Little
Hovingh, G. Kees
Kastelein, John J. P.
CIRCULATION, 2016, 134 (10) : 710 - 712
[25] What special considerations must be made for the pharmacotherapeutic management of heterozygous familial hypercholesterolemia?
Polychronopoulos, Georgios
Tziomalos, Konstantinos
EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (10) : 1175 - 1180
[26] Management of familial heterozygous hypercholesterolemia: Position Paper of the Polish Lipid Expert Forum
Rynkiewicz, Andrzej
Cybulska, Barbara
Banach, Maciej
Fitipiak, Krzysztof
Guzik, Tomasz
Idzior-Walus, Barbara
Imiela, Jacek
Jankowski, Piotr
Klosiewicz-Latoszek, Longina
Limon, Janusz
Mysliwiec, Malgorzata
Opolski, Grzegorz
Steciwko, Andrzej
Stepinska, Janina
Zdrojewski, Tomasz
JOURNAL OF CLINICAL LIPIDOLOGY, 2013, 7 (03) : 217 - 221
[27] EFFICACY AND SAFETY OF SIMVASTATIN IN PRIMARY HYPERCHOLESTEROLEMIA
YOMTOV, B
CHATENETDUCHENE, L
SEMAINE DES HOPITAUX, 1995, 71 (7-8): : 249 - 254
[28] Early efficacy and safety of statin therapy in Korean patients with hypercholesterolemia: Daegu and Gyeongbuk Statin Registry
Bae, Han Joon
Cho, Yun-Kyeong
Park, Hyoung-Seob
Yoon, Hyuck-Jun
Kim, Hyungseop
Han, Seongwook
Hur, Seung-Ho
Kim, Yoon-Nyun
Kim, Kwon-Bae
Ryu, Jae-Kean
Nah, Deug Young
Nam, Chang-Wook
KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (02) : 342 - 350
[29] Efficacy and Safety of Ongericimab in Chinese Patients With Primary Hypercholesterolemia and Mixed Dyslipidemia
Wang, Xiaozeng
Qiu Miaohan
Cheng, Zhifeng
Ji, Xianyou
Chen, Jiyan
Zhu, Hong
Tang, Yida
Huang, Zhouqing
Su, Guohai
Wang, Gaopin
Huang, Zhijun
Yao, Zhuhua
Lin, Jinxiu
Sun, Yihong
Li, Shunhui
Shao, Cong
Yan, Hui
Zhao, Yi
Bai, Xuelian
Wang, Shi
Han Yaling
CIRCULATION, 2023, 148
[30] Efficacy and safety of proprotein convertase subtilisin/kexin type 9 monoclonal antibody in adults with familial hypercholesterolemia
Li, Bin
Hao, Pan-Pan
Zhang, Yong
Yin, Rui-Hong
Kong, Qing-Zan
Cai, Xiao-Jun
Zhao, Zhuo
Qi, Jian-Ni
Li, Ying
Xiao, Jie
Wang, Fu
Yi, Wei
Ji, Xiao-Ping
Su, Guo-Hai
ONCOTARGET, 2017, 8 (18) : 30455 - 30463

← 1 2 3 4 5 →